Vasoconstriction induced by activation of EP 1 and EP 3 receptors in human lung: Effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713

Prostaglandins and Other Lipid Mediators

Volumn 74, Issue 1-4, 2004, Pages 101-112

  Norel, Xavier ^a   Montpreville, Vincent De ^b   Brink, Charles ^a  

^a HÔPITAL BROUSSAIS   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Human pulmonary arteries; Human pulmonary veins; Prostaglandins

Indexed keywords

11,15 O DIMETHYLPROSTAGLANDIN E2; 2,5 ETHANO 6 OXO 17,20 DIMETHYLPROSTAGLANDIN E1; 4 [2 [N ISOBUTYL N (2 FURYLSULFONYL)AMINO] 5 TRIFLUOROMETHYLPHENOXYMETHYL] CINNAMIC ACID; 5 CARBAPROSTACYCLIN; 6 [3 (4 CHLORO 2 METHYLPHENYLSULFONYLAMINOMETHYL) BICYCLO[2.2.2]OCTAN 2 YL] 5 HEXENOIC ACID; 6 [3 (4 CHLORO 2 METHYLPHENYLSULFONYLAMINOMETHYL)BICYCLO[2.2.2]OCTAN 2 YL] 5 HEXENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ONO 8713; ONO AE 248; ONO DI 004; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID EP1 RECEPTOR; PROSTANOID EP1 RECEPTOR BLOCKING AGENT; PROSTANOID EP1 RECEPTOR STIMULATING AGENT; PROSTANOID EP3 RECEPTOR; PROSTANOID EP3 RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; RAMATROBAN; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; HUMAN; HUMAN TISSUE; LUNG BLOOD VESSEL; LUNG VASOCONSTRICTION; PULMONARY ARTERY; PULMONARY VEIN; RECEPTOR BLOCKING; VASODILATATION;

ALPROSTADIL; BICYCLO COMPOUNDS; CINNAMATES; DINOPROSTONE; FEMALE; HEXANOIC ACIDS; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY ARTERY; RECEPTORS, PROSTAGLANDIN E; VASOCONSTRICTION;

EID: 5444265539     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2004.07.003     Document Type: Article

References (54)

1. R.A. Coleman, W.L. Smith, and S. Narumiya International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol Rev 46 2 1994 205 229
2. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 4 1999 1193 1226
3. K. Tsuboi, Y. Sugimoto, and A. Ichikawa Prostanoid receptor subtypes Prostag Other Lipid Mediat 68/69 2002 535 556
4. M. Negishi, Y. Sugimoto, and A. Ichikawa Molecular mechanisms of diverse actions of prostanoid receptors Biochim Biophys Acta 1259 1 1995 109 119
5. X. Norel, C. Labat, and P.J. Gardiner Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations Br J Pharmacol 104 3 1991 591 595
6. 3-receptor agonists on human isolated pulmonary artery Br J Pharmacol 113 2 1994 369 374
7. X. Norel, L. Walch, and J.P. Gascard Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone Br J Pharmacol 142 4 2004 788 796
8. L. Walch, V. de Montpreville, and C. Brink Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins Br J Pharmacol 134 8 2001 1671 1678
9. T.K. Uski, K.E. Andersson, and L. Brandt Characterization of the prostanoid receptors and of the contractile effects of prostaglandin F2 alpha in human pial arteries Acta Physiol Scand 121 4 1984 369 378
10. E.H. Ohlstein, G.A. Kopia, and R.L. Zeid Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey and human coronary vasculature Prostaglandins 36 1 1988 69 84
11. D.E. Mais, D.L. Saussy Jr., and A. Chaikhouni Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors J Pharmacol Exp Therap 233 2 1985 418 424
12. A.A. Parsons, and E.T. Whalley Effects of prostanoids on human and rabbit basilar arteries precontracted in vitro Cephalalgia 9 3 1989 165 171
13. A.G. Templeton, J.C. McGrath, and M.J. Whittle The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery Br J Pharmacol 103 1 1991 1079 1084
14. M.A. Cruz, V. Gallardo, and P. Miguel Serotonin-induced vasoconstriction is mediated by thromboxane release and action in the human fetal-placental circulation Placenta 18 2/3 1997 197 204
15. R.A. Lawrence, R.L. Jones, and N.H. Wilson Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum Br J Pharmacol 105 2 1992 271 278
16. K. Zacharowski, A. Olbrich, and J. Piper Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents Arterioscler Thromb Vasc Biol 19 9 1999 2141 2147
17. H. Yamamoto, T. Maruyama, and K. Sakata Novel four selective agonists for prostaglandin E receptor subtypes Prostag Other Lipid Mediat 59 1-6 1999 150
18. T. Maruyama, and S. Ohuchida Selective agonists and antagonists for prostaglandin E2 receptor subtypes Tanpakushitsu Kakusan Koso 45 Suppl. 6 2000 1001 1007
19. 1 in colon carcinogenesis Cancer Res 59 20 1999 5093 5096
20. K. Watanabe, T. Kawamori, and S. Nakatsugi Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice Cancer Lett 156 1 2000 57 61
21. 3 and kappa-opioid receptor pathways in tactile pain induced by human immunodeficiency virus type-1 (HIV-1) glycoprotein gp120 Neuropharmacology 45 1 2003 96 105
22. A. Miura, M. Kawatani, and T. Maruyama Effect of prostaglandins on parasympathetic neurons in the rat lumbosacral spinal cord Neuroreport 13 12 2002 1557 1562
23. 3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324 Br J Pharmacol 125 6 1998 1288 1296
24. R.L. Jones, and K. Chan Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels Br J Pharmacol 134 2 2001 313 324
25. R.L. Jones, Y.M. Qian, and H. Wise Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery J Cardiovasc Pharmacol 29 4 1997 525 535
26. Y. Okada, A. Hara, and H. Ma Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors Br J Pharmacol 131 4 2000 745 755
27. T. Oka, K. Oka, and C.B. Saper Contrasting effects of E type prostaglandin (EP) receptor agonists on core body temperature in rats Brain Res 968 2 2003 256 262
28. 1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors Endocrinology 144 4 2003 1284 1291
29. I. Shibuya, K. Tanaka, and Y. Uezono Prostaglandin E2 induces Ca2+ release from ryanodine/caffeine-sensitive stores in bovine adrenal medullary cells via EP1-like receptors J Neurochem 73 5 1999 2167 2174
30. M. Arner, and E.D. Hogestatt Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries Acta Physiol Scand 142 2 1991 165 172
31. D. Abran, D.R. Varma, and D.Y. Li Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane Can J Physiol Pharmacol 72 2 1994 168 173
32. D. Abran, D.Y. Li, and D.R. Varma Characterization and ontogeny of PGE2 and PGF2 alpha receptors on the retinal vasculature of the pig Prostaglandins 50 5/6 1995 253 267
33. L. Tang, K. Loutzenhiser, and R. Loutzenhiser Biphasic actions of prostaglandin E(2) on the renal afferent arteriole: role of EP(3) and EP(4) receptors Circ Res 86 6 2000 663 670
34. A. Alhuwalia, S.A. Head, and R.L.G. Sheldrick Prostanoid receptors mediating contraction of rabbit renal artery Br J Pharmacol 95 Suppl. 1988 721P
35. C.R. Kennedy, Y. Zhang, and S. Brandon Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor Nat Med 5 2 1999 217 220
36. Y. Zhang, Y. Guan, and A. Schneider Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors Hypertension 35 5 2000 1129 1134
37. L.P. Audoly, X. Ruan, and V.A. Wagner Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics Am J Physiol Heart Circ Physiol 280 1 2001 327 333
38. K.E. Purdy, and W.J. Arendshorst EP(1) and EP(4) receptors mediate prostaglandin E(2) actions in the microcirculation of rat kidney Am J Physiol Renal Physiol 279 4 2000 755 764
39. 1 subtype in the development of renal injury in genetically hypertensive rats Hypertension 42 6 2003 1183 1190
40. M. Camacho, J. Lopez-Belmonte, and L. Vila Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity Circ Res 83 4 1998 353 365
41. F.Q. Wen, K. Watanabe, and M. Yoshida Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1 beta and TNF alpha Prostag Leukot Essent Fatty Acids 59 1 1998 71 75
42. M. Soler, M. Camacho, and J.R. Escudero Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase Circ Res 87 6 2000 504 507
43. G.E. Caughey, L.G. Cleland, and P.S. Penglis Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2 J Immunol 167 5 2001 2831 2838
44. X. Yang, K.K. Sheares, and N. Davie Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells Am J Respir Cell Mol Biol 27 6 2002 688 696
45. L. Gan, L.S. Sjogren, and R. Doroudi A new computerized biomechanical perfusion model for ex vivo study of fluid mechanical forces in intact conduit vessels J Vasc Res 36 1 1999 68 78
46. M. Imanishi, M. Kawamura, and S. Akabane Aspirin lowers blood pressure in patients with renovascular hypertension Hypertension 14 5 1989 461 468
47. A. Stock, R. Jones, and T. Chung Pulmonary edema in association with an intravenous infusion of sulprostone Acta Obstet Gynecol Scand 74 2 1995 156 158
48. G.J. Hofmeyr, V.C. Nikodem, and M. de Jager Side-effects of oral misoprostol in the third stage of labour - a randomised placebo-controlled trial South Afr Med J 91 5 2001 432 435
49. R. Naeije, C. Melot, and P. Mols Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease Am Rev Respir Dis 125 1 1982 1 5
50. H. Olschewski, F. Rose, and R. Schermuly Prostacyclin and its analogues in the treatment of pulmonary hypertension Pharmacol Therap 102 2 2004 139 153
51. H. Olschewski, D. Walmrath, and R. Schermuly Aerosolized prostacyclin and iloprost in severe pulmonary hypertension Ann Intern Med 124 9 1996 820 824
52. M. Kiriyama, F. Ushikubi, and T. Kobayashi Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells Br J Pharmacol 122 2 1997 217 224
53. 3 receptor Prostaglandins 48 5 1994 275 283
54. 3 subtype J Biol Chem 267 10 1992 6463 6466